These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 34857900)

  • 41. The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer's Disease.
    Wang Y
    CNS Neurol Disord Drug Targets; 2023; 22(4):577-598. PubMed ID: 35440320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome.
    Bicknell B; Liebert A; Borody T; Herkes G; McLachlan C; Kiat H
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction.
    Lee B; Lee SM; Song JW; Choi JW
    Biomol Ther (Seoul); 2024 Jul; 32(4):403-423. PubMed ID: 38898687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
    Kumar N; Sahoo NK; Mehan S; Verma B
    Mult Scler Relat Disord; 2023 Mar; 71():104547. PubMed ID: 36805171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut-microbiota derived bioactive metabolites and their functions in host physiology.
    Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK
    Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune-microbiome interplay and its implications in neurodegenerative disorders.
    Uniyal A; Tiwari V; Rani M; Tiwari V
    Metab Brain Dis; 2022 Jan; 37(1):17-37. PubMed ID: 34357554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crosstalk between gut microbiome and neuroinflammation in pathogenesis of HIV-associated neurocognitive disorder.
    Chen X; Wei J; Zhang Y; Zhang Y; Zhang T
    J Neurol Sci; 2024 Feb; 457():122889. PubMed ID: 38262196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.
    Ghaisas S; Maher J; Kanthasamy A
    Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut microbiota in neurological diseases: Melatonin plays an important regulatory role.
    Ahmadi S; Taghizadieh M; Mehdizadehfar E; Hasani A; Khalili Fard J; Feizi H; Hamishehkar H; Ansarin M; Yekani M; Memar MY
    Biomed Pharmacother; 2024 May; 174():116487. PubMed ID: 38518598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.
    Salminen A
    J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases.
    Zhou Y; Chen Y; He H; Peng M; Zeng M; Sun H
    Neuropharmacology; 2023 Nov; 239():109690. PubMed ID: 37619773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
    Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
    Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Impact of IgA and the Microbiota on CNS Disease.
    Pu A; Lee DSW; Isho B; Naouar I; Gommerman JL
    Front Immunol; 2021; 12():742173. PubMed ID: 34603329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS.
    Yousefi B; Babaeizad A; Banihashemian SZ; Feyzabadi ZK; Dadashpour M; Pahlevan D; Ghaffari H; Eslami M
    Curr Microbiol; 2022 Dec; 80(1):38. PubMed ID: 36527519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production of Psychoactive Metabolites by Gut Bacteria.
    Wiley NC; Cryan JF; Dinan TG; Ross RP; Stanton C
    Mod Trends Psychiatry; 2021; 32():74-99. PubMed ID: 34032647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease.
    Tran SM; Mohajeri MH
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33669008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of the host microbiome in autism and neurodegenerative disorders and effect of epigenetic procedures in the brain functions.
    Yousefi B; Kokhaei P; Mehranfar F; Bahar A; Abdolshahi A; Emadi A; Eslami M
    Neurosci Biobehav Rev; 2022 Jan; 132():998-1009. PubMed ID: 34742725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Microbe-gut-brain axis and neurological disorders: a review].
    Shen X; Sun Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3781-3788. PubMed ID: 34841783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.